The washouts of discarded bone marrow collection bags and filters are a very abundant source of hMSCs

被引:21
作者
Capelli, Chiara [1 ]
Salvade, Agnese [2 ]
Pedrini, Olga [1 ]
Barbui, Valentina [1 ]
Gotti, Elisa [1 ]
Borleri, Gianmaria [1 ]
Cabiati, Benedetta [2 ]
Belotti, Daniela [2 ]
Perseghin, Paolo [2 ,3 ]
Bellavita, Piero [4 ]
Biondi, Andrea [2 ]
Biagi, Ettore [2 ]
Rambaldi, Alessandro [1 ]
Golay, Josee [1 ]
Introna, Martino [1 ]
机构
[1] Osped Riuniti Bergamo, Lab Cell Therapy G Lanzani, USC Hematol, I-24128 Bergamo, Italy
[2] Univ Milano Bicocca, Osped Sand Gerardo, Lab Cell Therapy Stefano Verri, Tettamanti Res Ctr, Monza, Italy
[3] Osped San Gerardo, Unita Aferesi Terapeut, Serv Trasfus, Monza, Italy
[4] Osped Riuniti Bergamo, Serv Immunoematol & Med Trasfus, I-24100 Bergamo, Italy
关键词
Graft-versus-host disease; human platelet lysate; mesenchymal stromal cells; MESENCHYMAL STROMAL CELLS; VERSUS-HOST-DISEASE; HUMAN PLATELET LYSATE; STEM-CELLS; CULTURE-CONDITIONS; ANIMAL SERUM; EXPANSION; RESISTANT;
D O I
10.1080/14653240902960437
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Background aims Human multipotent mesenchymal stromal cells (hMSC) are considered good candidates for a growing spectrum of cell therapies. We have validated a protocol that makes use of the washouts of discarded collection sets, left over at the end of the filtration of bone marrow (BM) explants performed for hematopoietic stem cell (HSC) transplantation. Methods The method consists of direct plating of cells without density-gradient isolation followed by two detachment steps and expansion in 5% human platelet lysate (hPL). Results In a median of 26 days, 14 bags for adult patients and nine bags for pediatric patients for a standard dose of 1 x 10(6) hMSC/kg body weight could be prepared from the expansion of a fraction of the cells recovered from seven independent washouts. Moreover, 151 vials could be frozen from the remaining cells. The theoretical full expansion of all the frozen vials (validated by the expansion of two independent vials) could have allowed the production of 173 bags for adults and 348 bags for pediatric patients. Conclusions The washouts of discarded bags and filters left over at the end of routine BM explants filtration are a very abundant source of hMSC precursors that can be easily utilized for clinical applications.
引用
收藏
页码:403 / 413
页数:11
相关论文
共 20 条
[1]   Human platelet lysate allows expansion and clinical grade production of mesenchymal stromal cells from small samples of bone marrow aspirates or marrow filter washouts [J].
Capelli, C. ;
Domenghini, M. ;
Borleri, G. ;
Bellavita, P. ;
Poma, R. ;
Carobbio, A. ;
Mico, C. ;
Rambaldi, A. ;
Golay, J. ;
Introna, M. .
BONE MARROW TRANSPLANTATION, 2007, 40 (08) :785-791
[2]   Optimization of mesenchymal stem cell expansion procedures by cell separation and culture conditions modification [J].
Carrancio, Soraya ;
Lopez-Holgado, Natalia ;
Sanchez-Guijo, Fermin M. ;
Villaron, Eva ;
Barbado, Victoria ;
Tabera, Soraya ;
Diez-Campelo, Maria ;
Blanco, Juan ;
San Miguel, Jesuis F. ;
Consuelo del Canizo, M. .
EXPERIMENTAL HEMATOLOGY, 2008, 36 (08) :1014-1021
[3]  
CASPERSSON T, 1970, CHROMOSOMA, V30, P215
[4]  
CASTROMALASPINA H, 1980, BLOOD, V56, P289
[5]   Platelet lysates promote mesenchymal stem cell expansion: A safety substitute for animal serum in cell-based therapy applications [J].
Doucet, C ;
Ernou, I ;
Zhang, YZ ;
Llense, JR ;
Begot, L ;
Holy, X ;
Lataillade, JJ .
JOURNAL OF CELLULAR PHYSIOLOGY, 2005, 205 (02) :228-236
[6]   Isolation and characterization of mesenchymal stem cell population entrapped in bone marrow collection sets [J].
Dvorakova, Jana ;
Hruba, Alena ;
Velebny, Vladimir ;
Kubala, Lukas .
CELL BIOLOGY INTERNATIONAL, 2008, 32 (09) :1116-1125
[7]   Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transniantation and regenerative medicine [J].
Lange, Claudia ;
Cakiroglu, Figen ;
Spiess, Andrej-Nikolai ;
Cappallo-Obermann, Heike ;
Dierlamm, Judith ;
Zander, Axel R. .
JOURNAL OF CELLULAR PHYSIOLOGY, 2007, 213 (01) :18-26
[8]   Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells [J].
Le Blanc, K ;
Rasmusson, I ;
Sundberg, B ;
Götherström, C ;
Hassan, M ;
Uzunel, M ;
Ringdén, O .
LANCET, 2004, 363 (9419) :1439-1441
[9]   Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease:: a phase II study [J].
LeBlanc, Katarina ;
Frassoni, Francesco ;
Ball, Lynne ;
Locatelli, Franco ;
Roelofs, Helene ;
Lewis, Ian ;
Lanino, Edoardo ;
Sundberg, Berit ;
Bernardo, Maria Ester ;
Remberger, Mats ;
Dini, Giorgio ;
Egeler, R. Maarten ;
Bacigalupo, Andrea ;
Fibbe, Willem ;
Ringden, Olle .
LANCET, 2008, 371 (9624) :1579-1586
[10]   Isolation of large numbers of mesenchymal stem cells from the washings of bone marrow collection bags: Characterization of fresh mesenchymal stem cells [J].
Mageed, Aly S. ;
Pietryga, Daniel W. ;
DeHeer, David H. ;
Westl, Richard A. .
TRANSPLANTATION, 2007, 83 (08) :1019-1026